Abbott Laboratories Limited

Abbott House, Vanwall Business Park, Vanwall Road, Maidenhead, Berkshire, SL6 4XE, UK
Telephone: +44 (0)1628 773 355
Fax: +44 (0)1628 644 185
WWW: http://www.abbottuk.com
Medical Information e-mail: ukmedinfo@abbott.com
Out of Hours Telephone: +44 (0)1628 774 920

Summary of Product Characteristics last updated on the eMC: 20/07/2010
SPC Survanta

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 20/07/2010 and displayed until Current
Reasons for adding or updating:
  • Change to section 6.1 - List of Excipients
  • Change to section 10 date of revision of the text
Updated on 08/01/2010 and displayed until 20/07/2010
Reasons for adding or updating:
  • Change to section 7 - Marketing Authorisation Holder
Updated on 25/04/2006 and displayed until 08/01/2010
Reasons for adding or updating:
  • Change to section 8 - MA number
  • Change to section 10 (date of (partial) revision of the text
Updated on 09/03/2005 and displayed until 25/04/2006
Reasons for adding or updating:
  • Change to section 4.8 - Undesirable Effects
Updated on 09/07/2001 and displayed until 09/03/2005
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 25/04/2001 and displayed until 09/07/2001
Reasons for adding or updating:
  • No reasons supplied
Updated on 06/09/1999 and displayed until 25/04/2001
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
   beractant